Intellia Therapeutics Inc buy BMO Capital Markets
Start price
10.01.25
/
50%
€10.22
Target price
10.01.26
€48.67
Performance (%)
-11.94%
End price
11.01.26
€9.00
Summary
This prediction ended on 11.01.26 with a price of €9.00. The price of Intellia Therapeutics Inc has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -11.94%. BMO_Capital_Markets has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Intellia Therapeutics Inc | 32.064% | 32.064% | 28.004% |
| iShares Core DAX® | -1.673% | 2.237% | 16.344% |
| iShares Nasdaq 100 | -1.346% | 0.290% | 3.851% |
| iShares Nikkei 225® | -1.529% | 5.863% | 18.286% |
| iShares S&P 500 | -1.702% | 0.697% | 1.755% |
Comments by BMO_Capital_Markets for this prediction
In the thread Intellia Therapeutics Inc diskutieren
Intellia Therapeutics, Inc. (NASDAQ: NTLA) had its price target lowered by analysts at BMO Capital Markets from $70.00 to $50.00. They now have an "outperform" rating on the stock.
Ratings data for NTLA provided by MarketBeat
In the thread Trading Intellia Therapeutics Inc
Die von BMO_Capital_Markets gewählte maximale Laufzeit wurde überschritten
Stopped prediction by BMO_Capital_Markets for Intellia Therapeutics Inc
Intellia Therapeutics Inc
Start price
Target price
Perf. (%)
€22.72
10.05.24
10.05.24
€64.98
10.05.25
10.05.25
-67.39%
11.05.25
11.05.25
Intellia Therapeutics Inc
Start price
Target price
Perf. (%)
€22.58
10.11.23
10.11.23
€58.01
10.11.24
10.11.24
-30.16%
11.11.24
11.11.24
Intellia Therapeutics Inc
Start price
Target price
Perf. (%)
€36.37
13.03.23
13.03.23
-
13.03.24
13.03.24
-27.88%
14.03.24
14.03.24